Literature DB >> 19657235

Autophagy and the pancreatic beta-cell in human type 2 diabetes.

Piero Marchetti1, Matilde Masini.   

Abstract

Pancreatic beta-cell dysfunction is central to the development and worsening of type 2 diabetes. Whereas beta-cell apoptosis plays a major role in reducing beta-cell mass in diabetes, alterations of autophagy can also lead to beta-cell death, as recently demonstrated in type 2 diabetic subjects. In addition, several studies with cell lines and rodent models have shown the importance of autophagy in regulating beta-cell survival and function. Although most of the underlying molecular mechanisms remain to be elucidated, this growing evidence raises interest in the role of autophagy in beta-cell pathophysiology and suggests the possibility of exploring autophagic processes to develop tools for protection of the pancreatic beta-cell in type 2 diabetes.

Entities:  

Mesh:

Year:  2009        PMID: 19657235     DOI: 10.4161/auto.5.7.9511

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  16 in total

Review 1.  Regulation of SIRT1 in cellular functions: role of polyphenols.

Authors:  Sangwoon Chung; Hongwei Yao; Samuel Caito; Jae-Woong Hwang; Gnanapragasam Arunachalam; Irfan Rahman
Journal:  Arch Biochem Biophys       Date:  2010-05-05       Impact factor: 4.013

Review 2.  Mitochondrial dynamics in diabetes.

Authors:  Yisang Yoon; Chad A Galloway; Bong Sook Jhun; Tianzheng Yu
Journal:  Antioxid Redox Signal       Date:  2010-08-26       Impact factor: 8.401

3.  Effect and mechanisms of zinc supplementation in protecting against diabetic cardiomyopathy in a rat model of type 2 diabetes.

Authors:  Ying Lu; Ya Liu; Hongyan Li; Xue Wang; Wenjie Wu; Lichao Gao
Journal:  Bosn J Basic Med Sci       Date:  2015-02-05       Impact factor: 3.363

4.  A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus.

Authors:  Huibiao Quan; Huachuan Zhang; Weiping Wei; Tuanyu Fang; Daoxiong Chen; Kaining Chen
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

Review 5.  The emerging role of autophagy in the pathophysiology of diabetes mellitus.

Authors:  Claudio D Gonzalez; Myung-Shik Lee; Piero Marchetti; Massimo Pietropaolo; Roberto Towns; Maria I Vaccaro; Hirotaka Watada; John W Wiley
Journal:  Autophagy       Date:  2011-01-01       Impact factor: 16.016

6.  Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway.

Authors:  Haiyan Liu; Ali Javaheri; Rebecca J Godar; John Murphy; Xiucui Ma; Nidhi Rohatgi; Jana Mahadevan; Krzysztof Hyrc; Paul Saftig; Connie Marshall; Michael L McDaniel; Maria S Remedi; Babak Razani; Fumihiko Urano; Abhinav Diwan
Journal:  Autophagy       Date:  2017-11-25       Impact factor: 16.016

7.  Beta cell dysfunction and insulin resistance.

Authors:  Marlon E Cerf
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-27       Impact factor: 5.555

8.  Liraglutide protects pancreatic β-cells against free fatty acids in vitro and affects glucolipid metabolism in apolipoprotein E-/- mice by activating autophagy.

Authors:  Jia Wang; Jie Wu; Hong Wu; Xingzhen Liu; Yingjian Chen; Jianying Wu; Chengjin Hu; Dajin Zou
Journal:  Mol Med Rep       Date:  2015-06-16       Impact factor: 2.952

9.  Expression profiling pre-diabetic mice to uncover drugs with clinical application to type 1 diabetes.

Authors:  Dimeng Pang; Katharine M Irvine; Ahmed M Mehdi; Helen E Thomas; Mark Harris; Emma E Hamilton-Williams; Ranjeny Thomas
Journal:  Clin Transl Immunology       Date:  2015-08-28

10.  Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.

Authors:  Lalitha Gudipaty; Nora K Rosenfeld; Carissa S Fuller; Robert Gallop; Mark H Schutta; Michael R Rickels
Journal:  Diabetes Care       Date:  2014-06-26       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.